Podszywalow-Bartnicka Paulina, Wolczyk Magdalena, Kusio-Kobialka Monika, Wolanin Kamila, Skowronek Krzysztof, Nieborowska-Skorska Margaret, Dasgupta Yashodhara, Skorski Tomasz, Piwocka Katarzyna
a Laboratory of Cytometry; Nencki Institute of Experimental Biology ; Warsaw , Poland.
Cell Cycle. 2014;13(23):3727-41. doi: 10.4161/15384101.2014.965013.
BRCA1 tumor suppressor regulates crucial cellular processes involved in DNA damage repair and cell cycle control. We showed that expression of BCR-ABL1 correlates with decreased level of BRCA1 protein, which promoted aberrant mitoses and aneuploidy as well as altered DNA damage response. Using polysome profiling and luciferase-BRCA1 3'UTR reporter system here we demonstrate that downregulation of BRCA1 protein in CML is caused by inhibition of BRCA1 mRNA translation, but not by increased protein degradation or reduction of mRNA level and half-life. We investigated 2 mRNA-binding proteins - HuR and TIAR showing specificity to AU-Rich Element (ARE) sites in 3'UTR of mRNA. BCR-ABL1 promoted cytosolic localization of TIAR and HuR, their binding to BRCA1 mRNA and formation of the TIAR-HuR complex. HuR protein positively regulated BRCA1 mRNA stability and translation, conversely TIAR negatively regulated BRCA1 translation and was found localized predominantly in the cytosolic stress granules in CML cells. TIAR-dependent downregulation of BRCA1 protein level was a result of ER stress, which is activated in BCR-ABL1 expressing cells, as we previously shown. Silencing of TIAR in CML cells strongly elevated BRCA1 level. Altogether, we determined that TIAR-mediated repression of BRCA1 mRNA translation is responsible for downregulation of BRCA1 protein level in BCR-ABL1 -positive leukemia cells. This mechanism may contribute to genomic instability and provide justification for targeting PARP1 and/or RAD52 to induce synthetic lethality in "BRCAness" CML and BCR-ABL1 -positive ALL cells.
BRCA1肿瘤抑制因子调节DNA损伤修复和细胞周期控制中涉及的关键细胞过程。我们发现BCR-ABL1的表达与BRCA1蛋白水平降低相关,这促进了异常有丝分裂和非整倍体形成以及DNA损伤反应改变。在此,我们使用多核糖体分析和荧光素酶-BRCA1 3'UTR报告系统证明,慢性粒细胞白血病(CML)中BRCA1蛋白的下调是由BRCA1 mRNA翻译受抑制引起的,而非蛋白质降解增加或mRNA水平及半衰期降低所致。我们研究了两种mRNA结合蛋白——HuR和TIAR,它们对mRNA 3'UTR中的富含AU元件(ARE)位点具有特异性。BCR-ABL1促进TIAR和HuR的胞质定位、它们与BRCA1 mRNA的结合以及TIAR-HuR复合物的形成。HuR蛋白正向调节BRCA1 mRNA的稳定性和翻译,相反,TIAR负向调节BRCA1的翻译,并且在CML细胞中主要定位于胞质应激颗粒中。如我们之前所示,TIAR依赖的BRCA1蛋白水平下调是内质网应激的结果,内质网应激在表达BCR-ABL1的细胞中被激活。在CML细胞中沉默TIAR可显著提高BRCA1水平。总之,我们确定TIAR介导的对BRCA1 mRNA翻译的抑制是BCR-ABL1阳性白血病细胞中BRCA1蛋白水平下调的原因。这一机制可能导致基因组不稳定,并为靶向PARP1和/或RAD52以在“BRCA样”CML和BCR-ABL1阳性急性淋巴细胞白血病(ALL)细胞中诱导合成致死性提供依据。